Mitchell Capital Management’s Celgene Corp CELG Stock Holding History

Mitchell Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-19,579	Closed	-$2.04M	–	121
2017 Q4	$2.04M	Sell	19,579 -27,179	-58%	-$3.07M	0.72%	41
2017 Q3	$6.82M	Buy	+46,758	New	+$6.37M	2.49%	17
2016 Q2	–	Sell	-91,550	Closed	-$9.16M	–	41
2016 Q1	$9.16M	Buy	91,550 +1,804	+2%	+$186K	3.15%	13
2015 Q4	$10.7M	Buy	89,746 +264	+0.3%	+$30.5K	3.59%	15
2015 Q3	$9.68M	Buy	89,482 +47,089	+111%	+$5.84M	3.38%	14
2015 Q2	$4.91M	Buy	42,393 +559	+1%	+$63.9K	1.5%	29
2015 Q1	$4.82M	Buy	+41,834	New	+$5M	1.49%	28

Other funds holding CELG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Mitchell Capital Management's CELG Position: Q1 2018 in Review

Mitchell Capital Management sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 19,579 shares — an estimated $2.04M sold.

Mitchell Capital Management first reported a position in CELG in Q1 2015 and held it in 7 quarters. The position peaked at $10.7M in Q4 2015. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

Mitchell Capital Management reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
Mitchell Capital Management sold 19,579 Celgene Corp shares in Q1 2018, an estimated $2.04M.
Mitchell Capital Management first reported a position in Celgene Corp in Q1 2015 and held it in 7 quarters.
Mitchell Capital Management's Celgene Corp position peaked at $10.7M in Q4 2015.
1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Mitchell Capital Management's 13F filing for Q1 2018, filed 4 May 2018.